Intralipid protects the heart in late pregnancy against ischemia/reperfusion injury via Caveolin2/STAT3/GSK-3β pathway

J Mol Cell Cardiol. 2017 Jan:102:108-116. doi: 10.1016/j.yjmcc.2016.11.006. Epub 2016 Nov 12.

Abstract

Background: We recently demonstrated that the heart of late pregnant (LP) rodents is more prone to ischemia/reperfusion (I/R) injury compared to non-pregnant rodents. Lipids, particularly polyunsaturated fatty acids, have received special attention in the field of cardiovascular research. Here, we explored whether Intralipid (ITLD) protects the heart against I/R injury in LP rodents and investigated the mechanisms underlying this protection.

Methods and results: In-vivo female LP rat hearts or ex-vivo isolated Langendorff-perfused LP mouse hearts were subjected to ischemia followed by reperfusion with PBS or ITLD (one bolus of 5mg/kg of 20% in in-vivo and 1% in ex-vivo). Myocardial infarct size, mitochondrial calcium retention capacity, genome-wide expression profiling, pharmacological inhibition and co-immunoprecipitation were performed. One bolus of ITLD at reperfusion significantly reduced the in-vivo myocardial infarct size in LP rats (23.3±2% vs. 55.5±3.4% in CTRL, p<0.01). Postischemic administration of ITLD also protected the LP hearts against I/R injury ex-vivo. ITLD significantly increased the threshold for the opening of the mitochondrial permeability transition pore in response to calcium overload (nmol-calcium/mg-mitochondrial protein: 290±17 vs. 167±10 in CTRL, p<0.01) and significantly increased phosphorylation of STAT3 (1.8±0.08 vs. 1±0.16 in CTRL, p<0.05) and GSK-3β (2.63±0.55 vs. 1±0.0.34 in CTRL, p<0.05). The ITLD-induced cardioprotection was fully abolished by Stattic, a specific inhibitor of STAT3. Transcriptome analysis revealed caveolin 2 (Cav2) was significantly upregulated by ITLD in hearts of LP rats under I/R injury. Co-immunoprecipitation experiments showed that Cav2 interacts with STAT3.

Conclusions: ITLD protects the heart in late pregnancy against I/R injury by inhibiting the mPTP opening through Cav2/STAT3/GSK-3β pathway.

Keywords: Caveolin-2; Intralipid; Ischemia/reperfusion; Pregnancy; STAT3; mPTP.

MeSH terms

  • Animals
  • Calcium / metabolism
  • Caveolin 2 / metabolism*
  • Cluster Analysis
  • Disease Models, Animal
  • Emulsions / administration & dosage
  • Emulsions / pharmacology
  • Female
  • Gene Expression Profiling
  • Glycogen Synthase Kinase 3 beta / metabolism*
  • Mice
  • Mitochondria, Heart / metabolism
  • Mitochondrial Membrane Transport Proteins / antagonists & inhibitors
  • Mitochondrial Permeability Transition Pore
  • Myocardial Reperfusion Injury / genetics
  • Myocardial Reperfusion Injury / metabolism*
  • Myocardial Reperfusion Injury / pathology
  • Myocardial Reperfusion Injury / prevention & control
  • Permeability
  • Phospholipids / administration & dosage
  • Phospholipids / pharmacology*
  • Phosphorylation
  • Pregnancy
  • Protective Agents / administration & dosage
  • Protective Agents / pharmacology*
  • Protein Binding
  • Rats
  • STAT3 Transcription Factor / metabolism*
  • Signal Transduction / drug effects*
  • Soybean Oil / administration & dosage
  • Soybean Oil / pharmacology*
  • Time Factors
  • Transcriptome

Substances

  • Caveolin 2
  • Emulsions
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • Phospholipids
  • Protective Agents
  • STAT3 Transcription Factor
  • soybean oil, phospholipid emulsion
  • Soybean Oil
  • Glycogen Synthase Kinase 3 beta
  • Calcium